BROWN BROTHERS HARRIMAN & CO - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 316 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2019. The put-call ratio across all filers is 1.05 and the average weighting 0.3%.

Quarter-by-quarter ownership
BROWN BROTHERS HARRIMAN & CO ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2022$16,000
+14.3%
1,271
+29.0%
0.00%
Q2 2022$14,000
-86.7%
985
-86.5%
0.00%
-100.0%
Q1 2022$105,000
+303.8%
7,316
+381.9%
0.00%
Q2 2021$26,000
+36.8%
1,518
+49.6%
0.00%
Q1 2021$19,000
-9.5%
1,015
-10.8%
0.00%
Q4 2020$21,000
+5.0%
1,1380.0%0.00%
Q3 2020$20,0000.0%1,1380.0%0.00%
Q2 2020$20,000
+5.3%
1,138
-8.7%
0.00%
Q1 2020$19,000
+216.7%
1,247
+235.2%
0.00%
Q3 2019$6,000
+100.0%
372
+188.4%
0.00%
Q1 2019$3,000129
+344.8%
0.00%
Q4 2018$0290.00%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q3 2019
NameSharesValueWeighting ↓
TFG Asset Management GP Ltd 1,903,662$29,449,6525.37%
MANAGED ASSET PORTFOLIOS, LLC 1,736,416$26,862,3564.12%
Y.D. More Investments Ltd 1,381,550$21,372,5794.11%
Clean Yield Group 533,157$8,167,9653.62%
XY Capital Ltd 143,697$2,222,9931.28%
Mondrian Investment Partners LTD 4,081,715$61,225,7251.26%
Capricorn Fund Managers Ltd 204,892$3,169,6791.10%
Legacy Wealth Asset Management, LLC 124,967$1,933,2390.71%
HAP Trading, LLC 263,679$4,079,1140.65%
BRANDES INVESTMENT PARTNERS, LP 1,802,036$27,877,4930.54%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders